Continuous clinical evidence for software that never stops changing

Post-market clinical follow-up for SaMD is structurally different from hardware. Software updates continuously, which means clinical evidence requirements don't stop at launch. Manufacturers need a systematic approach to generating, evaluating, and documenting clinical evidence throughout the product lifecycle, not just before submission.

In this session from the Greenlight Guru Software Enabled Devices Virtual Summit, we walk through what continuous clinical evidence collection looks like for SaMD, how to build a post-market clinical follow-up plan that scales with software updates, and what regulators are looking for in post-market surveillance for software devices.

Watch now!